Metabolomic Profiling in Colorectal Cancer: Opportunities for Personalized Medicine

• Fearnhead NS , WildingJL, BodmerWF. Genetics of colorectal cancer: hereditary aspects and overview of colorectal tumorigenesis. Br. Med. Bull.64 , 27–43 (2002).
   PubMed Web of Science ®Google Scholar
• Marshall JR . Prevention of colorectal cancer: diet, chemoprevention, and lifestyle. Gastroenterol. Clin. North Am.37(1) , 73–82 (2008).
   PubMed Web of Science ®Google Scholar
• McGarr SE , RidlonJM, HylemonPB. Diet, anaerobic bacterial metabolism, and colon cancer: a review of the literature. J. Clin. Gastroenterol.39(2) , 98–109 (2005).
   PubMed Web of Science ®Google Scholar
• Leddin D , HuntR, ChampionM et al. Canadian Association of Gastroenterology and the Canadian Digestive Health Foundation: Guidelines on colon cancer screening. Can. J. Gastroenterol. 18(2) , 93–99 (2004).
   PubMed Web of Science ®Google Scholar
• Rex DK , JohnsonDA, AndersonJC et al. American College of Gastroenterology guidelines for colorectal cancer screening 2009 [corrected]. Am. J. Gastroenterol. 104(3) , 739–750 (2009).
   PubMed Web of Science ®Google Scholar
• O‘Leary BA , OlynykJK, NevilleAM, PlatellCF. Cost–effectiveness of colorectal cancer screening: comparison of community-based flexible sigmoidoscopy with fecal occult blood testing and colonoscopy. J. Gastroenterol. Hepatol.19(1) , 38–47 (2004).
   PubMed Web of Science ®Google Scholar
• LaPointe LC , PedersenSK, DunneR et al. Discovery and validation of molecular biomarkers for colorectal adenomas and cancer with application to blood testing. PLoS ONE 7(1) , e29059 (2012).
   PubMed Web of Science ®Google Scholar
• Wang H , TsoVK, SlupskyCM, FedorakRN. Metabolomics and detection of colorectal cancer in humans: a systematic review. Future Oncol.6(9) , 1395–1406 (2010).
   PubMed Web of Science ®Google Scholar
• Ang CS , PhungJ, NiceEC. The discovery and validation of colorectal cancer biomarkers. Biomed. Chromatogr.25(1–2) , 82–99 (2011).
   PubMed Web of Science ®Google Scholar
• Cheng Y , XieG, ChenT et al. Distinct urinary metabolic profile of human colorectal cancer. J. Proteome Res. 11(2) , 1354–1363 (2012).
   PubMed Web of Science ®Google Scholar
• Romero R , EspinozaJ, GotschF et al. The use of high-dimensional biology (genomics, transcriptomics, proteomics, and metabolomics) to understand the preterm parturition syndrome. BJOG 113(Suppl. 3) , 118–135 (2006).
   PubMed Web of Science ®Google Scholar
• Nambiar PR , GuptaRR, MisraV. An “omics” based survey of human colon cancer. Mutat. Res.693(1–2) , 3–18 (2010).
   PubMed Web of Science ®Google Scholar
• Griffin JL , ShockcorJP. Metabolic profiles of cancer cells. Nat. Rev. Cancer4(7) , 551–561 (2004).
   PubMed Web of Science ®Google Scholar
• Kleivi K , LindGE, DiepCB et al. Gene expression profiles of primary colorectal carcinomas, liver metastases, and carcinomatoses. Mol. Cancer 6 , 2 (2007).
   PubMed Web of Science ®Google Scholar
• Solmi R , UgoliniG, RosatiG et al. Microarray-based identification and RT-PCR test screening for epithelial-specific mRNAs in peripheral blood of patients with colon cancer. BMC Cancer 6 , 250 (2006).
   PubMed Web of Science ®Google Scholar
• Komori T , TakemasaI, HiguchiH et al. Identification of differentially expressed genes involved in colorectal carcinogenesis using a cDNA microarray. J. Exp. Clin. Cancer Res. 23(3) , 521–527 (2004).
   PubMed Web of Science ®Google Scholar
• Backert S , GelosM, KobalzU et al. Differential gene expression in colon carcinoma cells and tissues detected with a cDNA array. Int. J. Cancer 82(6) , 868–874 (1999).
   PubMed Web of Science ®Google Scholar
• Chen WD , HanZJ, SkoletskyJ et al. Detection in fecal DNA of colon cancer-specific methylation of the nonexpressed vimentin gene. J. Natl Cancer Inst. 97(15) , 1124–1132 (2005).
   PubMedGoogle Scholar
• Leung WK , ToKF, ManEP et al. Quantitative detection of promoter hypermethylation in multiple genes in the serum of patients with colorectal cancer. Am. J. Gastroenterol. 100(10) , 2274–2279 (2005).
   PubMed Web of Science ®Google Scholar
• Ward DG , SuggettN, ChengY et al. Identification of serum biomarkers for colon cancer by proteomic analysis. Br J. Cancer 94(12) , 1898–1905 (2006).
   PubMed Web of Science ®Google Scholar
• Mazzanti R , SolazzoM, FantappieO et al. Differential expression proteomics of human colon cancer. Am. J. Physiol. Gastrointest. Liver Physiol. 290(6) , G1329–G1338 (2006).
   PubMed Web of Science ®Google Scholar
• Roblick UJ , HirschbergD, HabermannJK et al. Sequential proteome alterations during genesis and progression of colon cancer. Cell. Mol. Life Sci. 61(10) , 1246–1255 (2004).
   PubMed Web of Science ®Google Scholar
• Ritchie SA , AhiahonuPW, JayasingheD et al. Reduced levels of hydroxylated, polyunsaturated ultra long-chain fatty acids in the serum of colorectal cancer patients: implications for early screening and detection. BMC Med. 8 , 13 (2010).
   PubMed Web of Science ®Google Scholar
• Kaddurah-Daouk R , KristalBS, WeinshilboumRM. Metabolomics: a global biochemical approach to drug response and disease. Annu. Rev. Pharmacol. Toxicol.48 , 653–683 (2008).
   PubMed Web of Science ®Google Scholar
• Williams MD , ReevesR, ResarLS, HillHH Jr. Metabolomics of colorectal cancer: past and current analytical platforms. Anal. Bioanal. Chem.405(15) , 5013–5030 (2013).
   PubMed Web of Science ®Google Scholar
• Nicholson JK , LindonJC, HolmesE. ‘Metabonomics‘: understanding the metabolic responses of living systems to pathophysiological stimuli via multivariate statistical analysis of biological NMR spectroscopic data. Xenobiotica29(11) , 1181–1189 (1999).
   PubMed Web of Science ®Google Scholar
• Oliver SG . Functional genomics: lessons from yeast. Phil. Trans. R. Soc. Lond. B.357(1417) , 17–23 (2002).
   PubMed Web of Science ®Google Scholar
• Chan EC , KohPK, MalM et al. Metabolic profiling of human colorectal cancer using high-resolution magic angle spinning nuclear magnetic resonance (HR-MAS NMR) spectroscopy and gas chromatography mass spectrometry (GC/MS). J. Proteome Res. 8(1) , 352–361 (2009).
   PubMed Web of Science ®Google Scholar
• Wang M , LamersRJ, KorthoutHA et al. Metabolomics in the context of systems biology: bridging traditional Chinese medicine and molecular pharmacology. Phytother. Res. 19(3) , 173–182 (2005).
   PubMed Web of Science ®Google Scholar
• Abrahams E , GinsburgGS, SilverM. The Personalized Medicine Coalition: goals and strategies. Am. J. Pharmacogenomics5(6) , 345–355 (2005).
   PubMedGoogle Scholar
• Sun J , BegerRD, SchnachenbergLK. Metabolomics as a tool for personalizing medicine: 2012 update. Per. Med.10(2) , 149–161 (2013).
   PubMed Web of Science ®Google Scholar
• Qiu Y , CaiG, SuM et al. Serum metabolite profiling of human colorectal cancer using GC-TOFMS and UPLC-QTOFMS. J. Proteome Res. 8(10) , 4844–4850 (2009).
   PubMed Web of Science ®Google Scholar
• Boger DL , HenriksenSJ, CravattBF. Oleamide: an endogenous sleep-inducing lipid and prototypical member of a new class of biological signaling molecules. Curr. Pharm. Des.4(4) , 303–314 (1998).
   PubMed Web of Science ®Google Scholar
• Thomas EA , CarsonMJ, NealMJ, SutcliffeJG. Unique allosteric regulation of 5-hydroxytryptamine receptor-mediated signal transduction by oleamide. Proc. Natl Acad. Sci. USA94(25) , 14115–14119 (1997).
   PubMed Web of Science ®Google Scholar
• Tan B , QiuY, ZouX et al. Metabonomics identifies serum metabolite markers of colorectal cancer. J. Proteome Res. 12(6) , 3000–3009 (2013).
   PubMed Web of Science ®Google Scholar
• Kondo Y , NishiumiS, ShinoharaM et al. Serum fatty acid profiling of colorectal cancer by gas chromatography/mass spectrometry. Biomark. Med. 5(4) , 451–460 (2011).
   PubMed Web of Science ®Google Scholar
• Nomura DK , LongJZ, NiessenS et al. Monoacylglycerol lipase regulates a fatty acid network that promotes cancer pathogenesis. Cell 140(1) , 49–61 (2010).
   PubMed Web of Science ®Google Scholar
• Yang YJ , LeeSH, HongSJ, ChungBC. Comparison of fatty acid profiles in the serum of patients with prostate cancer and benign prostatic hyperplasia. Clin. Biochem.32(6) , 405–409 (1999).
   PubMed Web of Science ®Google Scholar
• Connolly JM , ColemanM, RoseDP. Effects of dietary fatty acids on DU145 human prostate cancer cell growth in athymic nude mice. Nutr. Cancer29(2) , 114–119 (1997).
   PubMed Web of Science ®Google Scholar
• Kriat M , Vion-DuryJ, Confort-GounyS et al. Analysis of plasma lipids by NMR spectroscopy: application to modifications induced by malignant tumors. J. Lipid Res. 34(6) , 1009–1019 (1993).
   PubMed Web of Science ®Google Scholar
• Ritchie SA , TonitaJ, AlviR et al. Low-serum GTA-446 anti-inflammatory fatty acid levels as a new risk factor for colon cancer. Int. J. Cancer 132(2) , 355–362 (2013).
   PubMed Web of Science ®Google Scholar
• Berger M , GrayJA, RothBL. The expanded biology of serotonin. Annu. Rev. Med.60 , 355–366 (2009).
   PubMed Web of Science ®Google Scholar
• Bertini I , CacciatoreS, JensenBV et al. Metabolomic NMR fingerprinting to identify and predict survival of patients with metastatic colorectal cancer. Cancer Res. 72(1) , 356–364 (2012).
   PubMed Web of Science ®Google Scholar
• Ma Y , ZhangP, WangF et al. An integrated proteomics and metabolomics approach for defining oncofetal biomarkers in the colorectal cancer. Ann. Surg. 255(4) , 720–730 (2012).
   PubMed Web of Science ®Google Scholar
• Qiu Y , CaiG, SuM et al. Urinary metabonomic study on colorectal cancer. J. Proteome Res. 9(3) , 1627–1634 (2010).
   PubMed Web of Science ®Google Scholar
• Chen JL , FanJ, YanLS et al. Urine metabolite profiling of human colorectal cancer by capillary electrophoresis mass spectrometry based on MRB. Gastroenterol. Res. Pract. 2012 , 125890 (2012).
   PubMed Web of Science ®Google Scholar
• Zhao L , WangH, SunX, DingY. Comparative proteomic analysis identifies proteins associated with the development and progression of colorectal carcinoma. FEBS J.277(20) , 4195–4204 (2010).
   PubMed Web of Science ®Google Scholar
• Shrubsole MJ , CaiQ, WenW et al. Urinary prostaglandin E2 metabolite and risk for colorectal adenoma. Cancer Prev. Res. (Phila.) 5(2) , 336–342 (2012).
   PubMed Web of Science ®Google Scholar
• Saric J , WangY, LiJ et al. Species variation in the fecal metabolome gives insight into differential gastrointestinal function. J. Proteome Res. 7(1) , 352–360 (2008).
   PubMed Web of Science ®Google Scholar
• Monleón D , MoralesJM, BarrasaA et al. Metabolite profiling of fecal water extracts from human colorectal cancer. NMR Biomed. 22(3) , 342–348 (2009).
   PubMed Web of Science ®Google Scholar
• Hassig CA , TongJK, SchreiberSL. Fiber-derived butyrate and the prevention of colon cancer. Chem. Biol.4(11) , 783–789 (1997).
   PubMedGoogle Scholar
• Pouillart PR . Role of butyric acid and its derivatives in the treatment of colorectal cancer and hemoglobinopathies. Life Sci.63(20) , 1739–1760 (1998).
   PubMed Web of Science ®Google Scholar
• Boffa LC , LuptonJR, MarianiMR et al. Modulation of colonic epithelial cell proliferation, histone acetylation, and luminal short chain fatty acids by variation of dietary fiber (wheat bran) in rats. Cancer Res. 52(21) , 5906–5912 (1992).
   PubMed Web of Science ®Google Scholar
• Domon-Dell C , WangQ, KimS et al. Stimulation of the intestinal Cdx2 homeobox gene by butyrate in colon cancer cells. Gut 50(4) , 525–529 (2002).
   PubMed Web of Science ®Google Scholar
• Hague A , ParaskevaC. The short-chain fatty acid butyrate induces apoptosis in colorectal tumour cell lines. Eur. J. Cancer Prev.4(5) , 359–364 (1995).
   PubMed Web of Science ®Google Scholar
• Abrahamse SL , Pool-ZobelBL, RechkemmerG. Potential of short chain fatty acids to modulate the induction of DNA damage and changes in the intracellular calcium concentration by oxidative stress in isolated rat distal colon cells. Carcinogenesis20(4) , 629–634 (1999).
   PubMed Web of Science ®Google Scholar
• Jimenez B , MirnezamiR, KinrossJ et al. 1H HR-MAS NMR spectroscopy of tumor-induced local metabolic “field-effects” enables colorectal cancer staging and prognostication. J. Proteome Res. 12(2) , 959–968 (2013).
   PubMed Web of Science ®Google Scholar
• Chen W , ZhouX, HuangD, ChenF, DuX. Metabolic profiling of human colorectal cancer using high resolution 1H nuclear magnetic resonance spectroscopy. Clin. J. Chem.29 , 2511–2519 (2011).
   Google Scholar
• Hirayama A , KamiK, SugimotoM et al. Quantitative metabolome profiling of colon and stomach cancer microenvironment by capillary electrophoresis time-of-flight mass spectrometry. Cancer Res. 69(11) , 4918–4925 (2009).
   PubMed Web of Science ®Google Scholar
• Tessem MB , SelnaesKM, SjursenW et al. Discrimination of patients with microsatellite instability colon cancer using 1H HR MAS MR spectroscopy and chemometric analysis. J. Proteome Res. 9(7) , 3664–3670 (2010).
   PubMed Web of Science ®Google Scholar
• Chae YK , KangWY, KimSH et al. combining information of common metabolites reveals global differences between colorectal cancerous and normal tissues. Bull. Korean Chem. Soc. 31(2) , 379–383 (2010).
   Web of Science ®Google Scholar
• Mal M , KohPK, CheahPY, ChanEC. Metabotyping of human colorectal cancer using two-dimensional gas chromatography mass spectrometry. Anal. Bioanal. Chem.403(2) , 483–493 (2012).
   PubMed Web of Science ®Google Scholar
• Mal M , KohPK, CheahPY, ChanEC. Development and validation of a gas chromatography/mass spectrometry method for the metabolic profiling of human colon tissue. Rapid Commun. Mass Spectrom.23(4) , 487–494 (2009).
   PubMed Web of Science ®Google Scholar
• Righi V , DuranteC, CocchiM et al. Discrimination of healthy and neoplastic human colon tissues by ex vivo HR-MAS NMR spectroscopy and chemometric analyses. J. Proteome Res. 8(4) , 1859–1869 (2009).
   PubMed Web of Science ®Google Scholar
• Piotto M , Moussallieh F-M, Dillmann B et al. Metabolic characterization of primary human colorectal cancers using high resolution magic angle spinning 1H magnetic resonance spectroscopy. Metabolomics5 , 292–301 (2009).
   Web of Science ®Google Scholar
• Warburg O . On the origin of cancer cells. Science123(3191) , 309–314 (1956).
   PubMed Web of Science ®Google Scholar
• Burg MB . Molecular basis of osmotic regulation. Am. J. Physiol.268(6 Pt 2) , F983–F996 (1995).
   PubMedGoogle Scholar
• Droge W . Autophagy and aging – importance of amino acid levels. Mech. Ageing Dev.125(3) , 161–168 (2004).
   PubMed Web of Science ®Google Scholar
• Mizushima N , KlionskyDJ. Protein turnover via autophagy: implications for metabolism. Annu. Rev. Nutr.27 , 19–40 (2007).
   PubMed Web of Science ®Google Scholar
• Sato K , TsuchiharaK, FujiiS et al. Autophagy is activated in colorectal cancer cells and contributes to the tolerance to nutrient deprivation. Cancer Res. 67(20) , 9677–9684 (2007).
   PubMed Web of Science ®Google Scholar
• Nishiumi S , KobayashiT, IkedaA et al. A novel serum metabolomics-based diagnostic approach for colorectal cancer. PLoS ONE 7(7) , e40459 (2012).
   PubMed Web of Science ®Google Scholar
• Andre N , SchmiegelW. Chemoradiotherapy for colorectal cancer. Gut54(8) , 1194–1202 (2005).
   PubMed Web of Science ®Google Scholar
• Claudino WM , GoncalvesPH, Di Leo A, Philip PA, Sarkar FH. Metabolomics in cancer: a bench-to-bedside intersection. Crit. Rev. Oncol. Hematol.84(1) , 1–7 (2012).
   PubMed Web of Science ®Google Scholar
• Zarbo RJ , MeierFA, RaabSS. Error detection in anatomic pathology. Arch. Pathol. Lab. Med.129(10) , 1237–1245 (2005).
   PubMed Web of Science ®Google Scholar
• Farshidfar F , WeljieAM, KopciukK et al. Serum metabolomic profile as a means to distinguish stage of colorectal cancer. Genome Med. 4(5) , 42 (2012).
   PubMedGoogle Scholar
• Nicholson JK , EverettJR, LindonJC. Longitudinal pharmacometabonomics for predicting patient responses to therapy: drug metabolism, toxicity and efficacy. Expert Opin. Drug Metab. Toxicol.8(2) , 135–139 (2012).
   PubMed Web of Science ®Google Scholar
• Backshall A , SharmaR, ClarkeSJ, KeunHC. Pharmacometabonomic profiling as a predictor of toxicity in patients with inoperable colorectal cancer treated with capecitabine. Clin. Cancer Res.17(9) , 3019–3028 (2011).
   PubMed Web of Science ®Google Scholar
• Robertson DG , WatkinsPB, ReilyMD. Metabolomics in toxicology: preclinical and clinical applications. Toxicol Sci.120(Suppl. 1) , S146–S170 (2011).
   PubMed Web of Science ®Google Scholar
• Kouskoumvekaki I , PanagiotouG. Navigating the human metabolome for biomarker identification and design of pharmaceutical molecules. J. Biomed. Biotechnol.2011, (2011).
   PubMedGoogle Scholar
• Boros LG , BrackettDJ, HarriganGG. Metabolic biomarker and kinase drug target discovery in cancer using stable isotope-based dynamic metabolic profiling (SIDMAP). Curr. Cancer Drug Targets3(6) , 445–453 (2003).
   PubMed Web of Science ®Google Scholar
• Bisogno T , KatayamaK, MelckD et al. Biosynthesis and degradation of bioactive fatty acid amides in human breast cancer and rat pheochromocytoma cells – implications for cell proliferation and differentiation. Eur. J. Biochem. 254(3) , 634–642 (1998).
   PubMedGoogle Scholar
• Kogan NM . Cannabinoids and cancer. Mini Rev. Med. Chem.5(10) , 941–952 (2005).
   PubMed Web of Science ®Google Scholar
• Bifulco M , Di Marzo V. Targeting the endocannabinoid system in cancer therapy: a call for further research. Nat. Med.8(6) , 547–550 (2002).
   PubMed Web of Science ®Google Scholar
• Patsos HA , HicksDJ, GreenhoughA, WilliamsAC, ParaskevaC. Cannabinoids and cancer: potential for colorectal cancer therapy. Biochem. Soc. Trans.33(Pt 4) , 712–714 (2005).
   PubMed Web of Science ®Google Scholar
• Ritchie SA , JayasingheD, DaviesGF et al. Human serum-derived hydroxy long-chain fatty acids exhibit anti-inflammatory and anti-proliferative activity. J. Exp. Clin. Cancer Res. 30 , 59 (2011).
   PubMed Web of Science ®Google Scholar
• Ritchie SA , HeathD, YamazakiY et al. Reduction of novel circulating long-chain fatty acids in colorectal cancer patients is independent of tumor burden and correlates with age. BMC Gastroenterol. 10 , 140 (2010).
   PubMed Web of Science ®Google Scholar
• Lindon JC , NicholsonJK, HolmesE et al. Summary recommendations for standardization and reporting of metabolic analyses. Nat. Biotechnol. 23(7) , 833–838 (2005).
   PubMed Web of Science ®Google Scholar
• Wishart DS . Trends in quantitative metabolomics. J. Biomol. Tech.21(Suppl. 3) , S6–S7 (2010).
   Google Scholar
• Kim DY , CamilleriM. Serotonin: a mediator of the brain-gut connection. Am. J. Gastroenterol.95(10) , 2698–2709 (2000).
   PubMed Web of Science ®Google Scholar
• Zheng X , XieG, ZhaoA et al. The footprints of gut microbial-mammalian co-metabolism. J. Proteome Res. 10(12) , 5512–5522 (2011).
   PubMed Web of Science ®Google Scholar
• Aziz Q , ThompsonDG. Brain-gut axis in health and disease. Gastroenterology114(3) , 559–578 (1998).
   PubMed Web of Science ®Google Scholar
• Kim YS , KimJJ, ChoKH et al. Biotransformation of ginsenoside Rb1, crocin, amygdalin, geniposide, puerarin, ginsenoside Re, hesperidin, poncirin, glycyrrhizin, and baicalin by human fecal microflora and its relation to cytotoxicity against tumor cells. J. Microbiol. Biotechnol. 18(6) , 1109–1114 (2008).
   PubMed Web of Science ®Google Scholar
• Martinez-García M , Diaz-ValdésM, Ramos-EspláA et al. Cytotoxicity of the ascidian Cystodytes dellechiajei against tumor cells and study of the involvement of associated microbiota in the production of cytotoxic compounds. Mar. Drugs 5(3) , 52–70 (2007).
   PubMed Web of Science ®Google Scholar
• Li Y , KunduP, SeowSW et al. Gut microbiota accelerate tumor growth via c-jun and STAT3 phosphorylation in APCMin/+ mice. Carcinogenesis 33(6) , 1231–1238 (2012).
   PubMed Web of Science ®Google Scholar

▪ Websites

• National Cancer Institute. Colon and rectal cancer. www.cancer.gov/cancertopics/types/colon-and-rectal
   Google Scholar
• COLOGIC simple colorectal cancer screening. Science and clinical benefits. http://cologiclabtest.com/science.html
   Google Scholar
• Biocrates Life Sciences. AbsoluteIDQ® p150 Kit. www.biocrates.com/products/research-products/absoluteidq-p150-kit
   Google Scholar